Nisin

Nisin is a peptide of 34 amino acids made by the bacterium Lactococcus lactis, the same species used to make cheese. It has been sold as a food preservative since the 1950s and carries the number E234 in the European Union[1][2]. Its gene codes for an ordinary chain of amino acids, but enzymes then rebuild that chain into a molecule with five rings and several amino acids that the genetic code does not contain[3].

This construction explains most of what makes nisin unusual. It kills bacteria at nanomolar concentrations because it grips a specific molecule in their membrane, and resistance to it has remained rare after decades of use[4]. It is also a well-documented example of how a peptide gets from a bacterial gene into the food supply.

Nisin A at a glance
ClassLantibiotic (class I bacteriocin)
ProducerLactococcus lactis
Length34 residues, from a 57-residue precursor
Formula, massC143H230N42O37S7, 3354 Da
RingsOne lanthionine and four methyllanthionines
ChargePositive: three lysines and two histidines, no acidic side chains
TargetLipid II, a building block of the bacterial cell wall
Active againstGram-positive bacteria and their spores
Food additiveE234; GRAS in the United States since 1988
Acceptable daily intake1 mg/kg body weight (EFSA, 2017)

From sour milk to E234

In 1928 researchers noticed that some strains of L. lactis inhibited the growth of related bacteria in fermented milk[3][2]. The active substance was partly purified in 1944, and nisin was first sold in England in 1953[3][2]. Its first commercial use was in cheese, against Clostridium tyrobutyricum, a spore-forming bacterium that produces gas and makes cheese swell late in ripening[1].

Regulators followed. The FAO/WHO expert committee accepted nisin as a food additive in 1969, the European Community listed it as E234 in 1983, and the US Food and Drug Administration recognised it as safe for processed cheese in 1988[2][1]. It is now permitted in more than 50 countries[2]. The chemistry came later: Gross and Morell published the structure in 1971, and the gene was cloned in 1988[3]. Among the many antibacterial peptides that bacteria make, nisin is one of the very few in commercial use[3][1].

Five rings in 34 residues

Nisin belongs to the lantibiotics, peptides named after the amino acid lanthionine. Lanthionine is two alanines joined at their β-carbons through a sulfur atom, a thioether bridge. When one of the two halves comes from threonine, the result carries an extra methyl group and is called methyllanthionine; that half is written Abu (aminobutyric acid)[3][4]. Mature nisin contains one lanthionine and four methyllanthionines, which close five rings labelled A to E. It also contains two dehydroalanines (Dha) and one dehydrobutyrine (Dhb), amino acids with a carbon–carbon double bond. Only 21 of the 34 residues are left unmodified[3].

Nisin A drawn as a chain of 34 residues in two rows. Rings A, B and C are closed by thioether bridges in the first 19 residues, a hinge of three residues follows, and the intertwined rings D and E lie between residues 23 and 28. Dehydro residues are at positions 2, 5 and 33.
Mature nisin A. Each ring is closed by a thioether bridge between an alanine or aminobutyric acid formed from serine or threonine and an alanine formed from cysteine. Rings A and B bind lipid II. Ring assignments from Lubelski et al. (2008)[3].

The rings give the molecule two parts. Rings A, B and C form the N-terminal half, which is mostly hydrophobic. A flexible hinge of three residues (Asn20–Met21–Lys22) links it to the intertwined rings D and E. Most of the positive charges sit in the C-terminal half[3]. Nisin has no aspartate or glutamate, so it carries a net positive charge, and no aromatic amino acids, so unlike most proteins it does not absorb light at 280 nm[1]. That is worth knowing when measuring it in the laboratory.

The modifications also change the mass. The gene-encoded sequence ITSISLCTPGCKTGALMGCNMKTATCHCSIHVSK would weigh about 3498 Da. Eight serines and threonines lose a water molecule each when they are dehydrated, which brings the mass to the 3354 Da given in the EU specification[5]. Closing a ring adds a cysteine's sulfur across a double bond and changes nothing further. A sequence-based tool such as the peptide calculator therefore gives the right answer only if these eight losses are subtracted.

How the bacterium builds it

Nisin is made on the ribosome like any protein, then modified. This places it among the ribosomally synthesised and post-translationally modified peptides, a route also described on the page about cyclic peptides. The gene nisA encodes a precursor of 57 residues. Its first 23 residues form a leader peptide, which the modifying enzymes use to recognise their substrate[3]. Four proteins carry out the main steps of maturation[3]:

  1. NisB, a dehydratase, removes water from selected serines and threonines, turning them into dehydroalanine and dehydrobutyrine.
  2. NisC, a cyclase, adds the thiol group of a cysteine across the double bond of a dehydrated residue, closing a thioether ring.
  3. NisT, a transporter, exports the modified precursor out of the cell.
  4. NisP, a protease outside the cell, cuts off the leader. Only then does nisin become active.

Keeping the leader attached until the peptide is outside protects the producer from its own product. The producer is also protected by two immunity systems, the lipoprotein NisI and the transporter NisFEG. Each provides only 5–20% of full immunity on its own, but together they protect fully[3].

Nisin also controls its own production. Mature nisin outside the cell binds a sensor kinase, NisK, in the membrane, which activates the regulator NisR and switches on the genes for more nisin and more immunity proteins[3]. As nisin accumulates outside the cells, it stimulates its own further production. This switch has been turned into a laboratory tool. In the nisin-controlled expression (NICE) system, added nisin switches on the production of other proteins in L. lactis, including membrane proteins that are notoriously hard to produce[3].

Because nisin is gene-encoded, its sequence can be changed simply by mutating the gene, and the bacterium's enzymes still install the rings. Many variants have been made this way, but few were more active than the natural peptide[3]. Some of the more active ones carry changes in the hinge[2]. Nature has produced at least eight variants. Nisin Z, from another L. lactis strain, differs from nisin A only at position 27, where asparagine replaces histidine, and is more soluble near neutral pH. Others, such as nisin F, Q, U, H and P, come from different strains and species[2][1].

Lipid II: a target, not just a membrane

Most antimicrobial peptides are drawn to bacterial membranes by charge and act at micromolar concentrations. Nisin is also cationic, but its potency comes from a specific target: lipid II, the carrier that moves cell wall building blocks across the bacterial membrane[3][4]. Rings A and B form a cage that holds the pyrophosphate group of lipid II[3]. The antibiotic vancomycin binds the same molecule, but at a different part[4].

Binding lipid II kills in two ways. It takes lipid II out of use, so the cell can no longer build its wall. And lipid II serves as an anchor for a pore through the membrane; in the proposed model of the pore, eight nisin molecules assemble with four lipid II molecules[3]. In artificial membranes containing lipid II, nanomolar nisin is enough to form pores. Without lipid II, micromolar concentrations are needed[3].

Nisin also stops bacterial spores from developing. In Bacillus anthracis it acts only after a spore begins to germinate, and nisin variants that still bind lipid II but cannot form pores no longer stop the spores[4]. This activity against spores is why nisin is used in heat-treated foods.

Nisin does not act on yeasts, moulds or viruses[1]. Gram-negative bacteria such as E. coli and Salmonella are protected by their outer membrane. They become sensitive only when that membrane is damaged, for example by the chelator EDTA, by heating or by high pressure[1].

Nisin in food

Nisin is used mainly in processed and ripened cheese, other dairy products, liquid egg, canned foods and some meat products[1][5]. Its main targets are Listeria monocytogenes, Clostridium botulinum and other spore-forming bacteria[1]. In the EU the maximum level in ripened and processed cheese is 12.5 mg/kg. In 2017 EFSA found no safety concern in extending its use to heat-treated meat products at up to 25 mg/kg[5].

Its chemistry dictates where it works. Nisin is most soluble and most stable in acid. Its solubility is 12% at pH 2.5, 4% at pH 5 and close to zero at neutral pH and above[1]. A solution at pH 3–3.5 survives 15 minutes at 121 °C with less than 10% loss, while more than 90% is lost at both pH 1 and pH 7[5]. In food it works less well than in a test tube, and about ten times more is needed[1]. Fat binds it, and in raw meat glutathione and proteases inactivate it quickly[1][5]. Its dehydro residues are also reactive and can take up water during storage, which slowly inactivates it[1].

Commercial nisin is not pure peptide. It is a fermentation product, concentrated, precipitated with salt and dried. The commercial powder contains a few percent nisin, with salt and milk solids making up the rest[5][1]. Its strength is therefore given in international units: 40 IU correspond to 1 µg of pure nisin[5][1].

Safety

Nisin taken with food is broken down by digestive enzymes, mainly pancreatic ones. After simulated digestion no intact nisin remains, only fragments with weak activity[5]. In 2017 the European Food Safety Authority reviewed it again. A 90-day feeding study in rats found no adverse effects even at the highest dose, about 225 mg of nisin per kg body weight per day. On this basis EFSA raised the acceptable daily intake from 0.13 to 1 mg/kg body weight. The FAO/WHO expert committee had set 2 mg/kg in 2013[5]. Estimated intake from food was below the new limit in all age groups[5].

The review deliberately left two questions out: whether nisin in food could lead to resistance in bacteria, and how it affects the gut microbiota. The panel recommended assessing the resistance risk separately, especially in view of a possible future use of nisin as a medicine[5].

Why resistance is rare

After decades of use, naturally occurring resistance to lantibiotics remains rare compared with resistance to conventional antibiotics. Most of what is known comes from strains made resistant in the laboratory[4][2]. One explanation offered is the target: lipid II is essential and hard for bacteria to change[2]. Bacteria with more or less lipid II do not differ in sensitivity, so the target itself does not seem to be what changes in resistant strains[4].

Instead, bacteria use general defences against cationic peptides. They add positively charged D-alanine to the teichoic acids of their cell wall, which repels nisin, change the lipids of their membrane, or thicken their wall[4]. A strain of Streptococcus thermophilus became resistant within two hours at low nisin concentrations by thickening its wall, and lost the resistance after four hours of growth without it[1].

A few mechanisms are aimed at nisin itself. The protein NSR, found in some L. lactis strains that do not make nisin, cuts the peptide bond between residues 28 and 29. The shortened nisin is about 100 times less active. Genes similar to nsr have been found in other species, including enterococci and staphylococci[4]. Some bacilli and other bacteria make nisinase, an enzyme that reduces the dehydroalanine next to the C-terminal lysine[4][2]. Food scientists regard resistant strains as a real limit on nisin's use[1], and reviewers stress that resistance should be watched if lantibiotics are used in medicine[2][4].

Beyond food

A long record in food has made nisin attractive for other uses, and a 2016 review collected many. Nisin kills methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci and oral bacteria in laboratory tests. It has been tested against mastitis in dairy cows, and in one study a topical treatment reduced staphylococci in the milk of women with mastitis. A nisin-releasing wound dressing reduced S. aureus in infected wounds in mice[2].

The same review describes nisin as a possible cancer treatment. It slowed the growth of head and neck cancer cells and tumours in mice[2]. These results come from cell and animal experiments, and much of the cited anticancer research was conducted by the review authors' research group[2]. Nisin is not an approved medicine for any condition. Its status as a safe food additive applies to the small amounts eaten in food, not to its use as a drug.

In short

  • Nisin is a 34-residue lantibiotic from Lactococcus lactis, used as food preservative E234 since the 1950s.
  • It is made on the ribosome and then modified by four enzymes, which create one lanthionine and four methyllanthionine rings and three dehydro residues.
  • It binds lipid II, which blocks cell wall synthesis and anchors pores, so it works at nanomolar concentrations against Gram-positive bacteria and their spores.
  • EFSA set its acceptable daily intake at 1 mg/kg body weight in 2017; nisin eaten in food is broken down by digestive enzymes.
  • Resistance is rare and mostly seen in the laboratory, but specific mechanisms such as the protease NSR exist; medical uses remain experimental.

References

  1. Gharsallaoui A, Oulahal N, Joly C, Degraeve P (2016). Nisin as a food preservative: part 1: physicochemical properties, antimicrobial activity, and main uses. Critical Reviews in Food Science and Nutrition 56:1262–1274. DOI: 10.1080/10408398.2013.763765
  2. Shin JM, Gwak JW, Kamarajan P, Fenno JC, Rickard AH, Kapila YL (2016). Biomedical applications of nisin. Journal of Applied Microbiology 120:1449–1465. DOI: 10.1111/jam.13033
  3. Lubelski J, Rink R, Khusainov R, Moll GN, Kuipers OP (2008). Biosynthesis, immunity, regulation, mode of action and engineering of the model lantibiotic nisin. Cellular and Molecular Life Sciences 65:455–476. DOI: 10.1007/s00018-007-7171-2
  4. Draper LA, Cotter PD, Hill C, Ross RP (2015). Lantibiotic resistance. Microbiology and Molecular Biology Reviews 79:171–191. DOI: 10.1128/MMBR.00051-14
  5. EFSA Panel on Food Additives and Nutrient Sources added to Food (2017). Safety of nisin (E 234) as a food additive in the light of new toxicological data and the proposed extension of use. EFSA Journal 15(12):5063. DOI: 10.2903/j.efsa.2017.5063